Susquehanna International Group
PJP icon

Susquehanna International Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Susquehanna International Group’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,825
Closed -$545K – 13554
2025
Q2 		$545K Sell
6,825
-3,686
-35% -$294K ﹤0.01% 8976
2025
Q1 		$910K Buy
10,511
+1,791
+21% +$153K ﹤0.01% 7487
2024
Q4 		$720K Sell
8,720
-2,499
-22% -$215K ﹤0.01% 7754
2024
Q3 		$976K Buy
+11,219
New +$960K ﹤0.01% 6840
2024
Q2 		– Sell
-9,332
Closed -$748K – 12953
2024
Q1 		$748K Sell
9,332
-2,637
-22% -$204K ﹤0.01% 7562
2023
Q4 		$911K Buy
11,969
+2,533
+27% +$181K ﹤0.01% 7209
2023
Q3 		$683K Buy
+9,436
New +$723K ﹤0.01% 7500
2023
Q2 		– Sell
-5,161
Closed -$394K – 12874
2023
Q1 		$392K Sell
5,161
-1,217
-19% -$93.8K ﹤0.01% 9140
2022
Q4 		$501K Sell
6,378
-12,421
-66% -$955K ﹤0.01% 7868
2022
Q3 		$1.34M Buy
18,799
+15,663
+499% +$1.17M ﹤0.01% 5873
2022
Q2 		$235K Sell
3,136
-16,965
-84% -$1.29M ﹤0.01% 10225
2022
Q1 		$1.6M Buy
20,101
+6,242
+45% +$484K ﹤0.01% 5979
2021
Q4 		$1.12M Sell
13,859
-7,690
-36% -$608K ﹤0.01% 6986
2021
Q3 		$1.67M Buy
21,549
+12,764
+145% +$1.03M ﹤0.01% 6232
2021
Q2 		$707K Buy
+8,785
New +$698K ﹤0.01% 8721
2021
Q1 		– Sell
-17,864
Closed -$1.39M – 12699
2020
Q4 		$1.28M Sell
17,864
-18,635
-51% -$1.25M ﹤0.01% 6110
2020
Q3 		$2.33M Buy
36,499
+24,276
+199% +$1.59M ﹤0.01% 4330
2020
Q2 		$791K Sell
12,223
-15,298
-56% -$951K ﹤0.01% 6415
2020
Q1 		$1.51M Sell
27,521
-4,853
-15% -$296K ﹤0.01% 4483
2019
Q4 		$2.1M Sell
32,374
-14,110
-30% -$859K ﹤0.01% 4249
2019
Q3 		$2.63M Buy
+46,484
New +$2.67M ﹤0.01% 3713
2019
Q2 		– Sell
-41,978
Closed -$2.74M – 10682
2019
Q1 		$2.74M Sell
41,978
-6,456
-13% -$424K ﹤0.01% 3275
2018
Q4 		$3.02M Buy
48,434
+40,933
+546% +$2.76M ﹤0.01% 2927
2018
Q3 		$551K Sell
7,501
-4,651
-38% -$334K ﹤0.01% 6343
2018
Q2 		$817K Sell
12,152
-1,306
-10% -$84K ﹤0.01% 5776
2018
Q1 		$840K Sell
13,458
-27,128
-67% -$1.79M ﹤0.01% 5619
2017
Q4 		$2.6M Buy
40,586
+14,930
+58% +$957K ﹤0.01% 3464
2017
Q3 		$1.68M Sell
25,656
-150
-0.6% -$9.47K ﹤0.01% 4237
2017
Q2 		$1.62M Buy
25,806
+424
+2% +$25.5K ﹤0.01% 4298
2017
Q1 		$1.49M Buy
25,382
+14,402
+131% +$842K ﹤0.01% 4290
2016
Q4 		$615K Buy
10,980
+544
+5% +$31.3K ﹤0.01% 6554
2016
Q3 		$643K Sell
10,436
-1,136
-10% -$74.4K ﹤0.01% 5593
2016
Q2 		$733K Sell
11,572
-68,275
-86% -$4.29M ﹤0.01% 5450
2016
Q1 		$4.8M Buy
79,847
+70,290
+735% +$4.3M ﹤0.01% 2356
2015
Q4 		$669K Sell
9,557
-23,035
-71% -$1.63M ﹤0.01% 6230
2015
Q3 		$2.16M Buy
32,592
+29,605
+991% +$2.3M ﹤0.01% 4123
2015
Q2 		$234K Sell
2,987
-14,346
-83% -$1.12M ﹤0.01% 9011
2015
Q1 		$1.32M Buy
+17,333
New +$1.27M ﹤0.01% 5184
2014
Q4 		– Sell
-26,945
Closed -$1.79M – 9978
2014
Q3 		$1.72M Buy
+26,945
New +$1.66M ﹤0.01% 4875
2014
Q2 		– Sell
-35,119
Closed -$2.04M – 10015
2014
Q1 		$1.99M Sell
35,119
-5,972
-15% -$339K ﹤0.01% 4370
2013
Q4 		$2.2M Buy
41,091
+24,362
+146% +$1.22M ﹤0.01% 4114
2013
Q3 		$770K Sell
16,729
-20,019
-54% -$913K ﹤0.01% 5731
2013
Q2 		$1.55M Buy
+36,748
New +$1.53M ﹤0.01% 4305

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's PJP Position: Q3 2025 in Review

Susquehanna International Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2025, closing a stake of 6,825 shares — an estimated $545K sold.

Susquehanna International Group first reported a position in PJP in Q2 2013 and held it in 43 quarters. The position peaked at $4.8M in Q1 2016. 93 funds tracked by Wall St. Rank hold PJP as of Q3 2025.

  • Susquehanna International Group reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 6,825 Invesco Pharmaceuticals ETF shares in Q3 2025, an estimated $545K.
  • Susquehanna International Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 43 quarters.
  • Susquehanna International Group's Invesco Pharmaceuticals ETF position peaked at $4.8M in Q1 2016.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.